STOP: The staff smoking project

A randomised feasibility study comparing a novel intervention for smoking cessation in NHS staff to standard care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN28976399

Enrollment

Registered

2020-02-21

Start date

2019-05-29

Completion date

Unknown

Last updated

2022-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation to prevent respiratory disease in hospital staff Respiratory

Interventions

The researchers will initially recruit 50 people to the study. Participants will be randomised to either standard care, or to receive our help to quit program. The researchers will advertise the study

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male or Female, aged 18 years or over 2. Willing and able to give informed consent for participation in the study. 3. Must work for PHT at QAH and be able to attend weekly meetings for the duration of the study period 4. Must be a current smoker

Exclusion criteria

Exclusion criteria: Unable to comprehend the study and provide informed consent e.g. insufficient command of English in the absence of someone to adequately interpret.

Design outcomes

Primary

Measure	Time frame
1. Study process indicators measured by: 1.1. The recruitment and retention rate 1.2. Process indicators measured by completion rates of outcome questionnaires and assessments 2. Qualitative outcomes measured by participants’ perceptions of the study, the intervention, including ease of attendance to group meetings and acceptability of the intervention 3. Clinical and behavioural outcomes measured by: 3.1. Number of smokers who achieved a successful quit measured at 4 weeks, 12 weeks and 6 months – smoking status Fagerstrom Test for Nicotine Dependence (FTND) 3.2. Spirometry at weekly intervals 3.3. Intention to stop smoking at baseline, 4, 12 and 24 weeks – intention to quit smoking questionnaire 3.4. Smoking behaviours at baseline, 4, 12 and 24 weeks – smoking specific compensatory health beliefs questionnaire 3.5. Smoking self efficacy at baseline, 4, 12 and 24 weeks – self efficacy to quit smoking questionnaire 3.6. Smoking self quality of life at baseline, 4, 12 and 24 weeks – quality of life questionnaire 3.7. Change in exercise behaviour at baseline, 4, 12 and 24 weeks – international physical activity questionnaire (short form) 3.8. Change in alcohol behaviour at baseline, 4, 12 and 24 weeks measured in units per week 3.9. Change in weight and BMI at baseline, 4, 12 and 24 weeks 4. Cost effectiveness outcomes measured by: 4.1. Number of sick days in the 6 months prior to intervention 4.2. Number of sick days during the intervention 4.3. Time spent away from the work place in the 6 months prior to the intervention (hours) 4.4. Time spent away from the work place during the intervention (hours) 4.5. Number of attendances at other NHS services seeking medical hel	—

Measure

Time frame

1. Study process indicators measured by: 1.1. The recruitment and retention rate 1.2. Process indicators measured by completion rates of outcome questionnaires and assessments 2. Qualitative outcomes measured by participants’ perceptions of the study, the intervention, including ease of attendance to group meetings and acceptability of the intervention 3. Clinical and behavioural outcomes measured by: 3.1. Number of smokers who achieved a successful quit measured at 4 weeks, 12 weeks and 6 months – smoking status Fagerstrom Test for Nicotine Dependence (FTND) 3.2. Spirometry at weekly intervals 3.3. Intention to stop smoking at baseline, 4, 12 and 24 weeks – intention to quit smoking questionnaire 3.4. Smoking behaviours at baseline, 4, 12 and 24 weeks – smoking specific compensatory health beliefs questionnaire 3.5. Smoking self efficacy at baseline, 4, 12 and 24 weeks – self efficacy to quit smoking questionnaire 3.6. Smoking self quality of life at baseline, 4, 12 and 24 weeks – quality of life questionnaire 3.7. Change in exercise behaviour at baseline, 4, 12 and 24 weeks – international physical activity questionnaire (short form) 3.8. Change in alcohol behaviour at baseline, 4, 12 and 24 weeks measured in units per week 3.9. Change in weight and BMI at baseline, 4, 12 and 24 weeks 4. Cost effectiveness outcomes measured by: 4.1. Number of sick days in the 6 months prior to intervention 4.2. Number of sick days during the intervention 4.3. Time spent away from the work place in the 6 months prior to the intervention (hours) 4.4. Time spent away from the work place during the intervention (hours) 4.5. Number of attendances at other NHS services seeking medical hel

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026